A propensity score-based case-control study of renin-angiotensin system gene polymorphisms and diastolic heart failure

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 497-502

  Wu, Cho Kai ^a   Luo, Jing Ling ^b   Wu, Xue Ming ^a,c   Tsai, Chia Ti ^a   Lin, Jou Wei ^a   Hwang, Juey Jen ^a   Lin, Jiunn Lee ^a   Tseng, Chuen Den ^a   Chiang, Fu Tien ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b KEELUNG HOSPITAL   (Taiwan)

^c TAOYUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

Angiotensin converting enzyme; Diastolic heart failure; Genetics; Polymorphism; Propensity score

Indexed keywords

ADENINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYTOSINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GUANINE; METHIONINE; NITRATE; THREONINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIASTOLIC HEART FAILURE; FEMALE; GENE DELETION; GENE INSERTION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

AGED; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HEART FAILURE, DIASTOLIC; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 67650899268     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.033     Document Type: Article

References (30)

1. Cowie M.R., Mosterd A., Wood D.A., et al. The epidemiology of heart failure. Eur Heart J 18 (1997) 208-225
2. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259
3. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., and Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
4. Oh J.K., Hatle L., Tajik A.J., and Little W.C. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 47 (2006) 500-506
5. Raman V.K., Lee Y.A., and Lindpaintner K. The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy. Am J Cardiol 76 (1995) 18D-23D
6. Dzau V.J. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 153 (1993) 937-942
7. Ju H., Scammel-La Fleur T., and Dixon I.M. Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II. J Mol Cell Cardiol 28 (1996) 1119-1128
8. Friedrich S.P., Lorell B.H., Rousseau M.F., et al. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 90 (1994) 2761-2771
9. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003) 777-781
10. Tribouilloy C., Rusinaru D., Leborgne L., Peltier M., Massy Z., and Slama M. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure. Am J Cardiol 101 (2008) 639-644
11. Tsai C.T., Lai L.P., Lin J.L., et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109 (2004) 1640-1646
12. Chiang F.T., Hsu K.L., Tseng C.D., et al. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens 15 (1997) 607-611
13. Hingorani A.D., Jia H., Stevens P.A., Hopper R., Dickerson J.E., and Brown M.J. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 13 (1995) 1602-1609
14. Inoue I., Nakajima T., Williams C.S., et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99 (1997) 1786-1797
15. Wu S.J., Chiang F.T., Jiang J.R., Hsu K.L., Chern T.H., and Tseng Y.Z. The G-217A variant of the angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese population. J Hypertens 21 (2003) 2061-2067
16. Angeja B.G., and Grossman W. Evaluation and management of diastolic heart failure. Circulation 107 (2003) 659-663
17. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J 19 (1998) 990-1003
18. Wang Y.C., Hwang J.J., Lai L.P., et al. Coexistence and exercise exacerbation of intraleft ventricular contractile dyssynchrony in hypertensive patients with diastolic heart failure. Am Heart J 154 (2007) 278-284
19. Haviland A., Nagin D.S., and Rosenbaum P.R. Combining propensity score matching and group-based trajectory analysis in an observational study. Psychol Methods 12 (2007) 247-267
20. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
21. James K.E., White R.F., and Kraemer H.C. Repeated split sample validation to assess logistic regression and recursive partitioning: an application to the prediction of cognitive impairment. Stat Med 24 (2005) 3019-3035
22. Rapp J.A., and Gheorghiade M. Role of neurohormonal modulators in heart failure with relatively preserved systolic function. Cardiol Clin 26 (2008) 23-40, vi
23. Schut A.F., Bleumink G.S., Stricker B.H., et al. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J 25 (2004) 2143-2148
24. Flesch M., Schiffer F., Zolk O., et al. Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. J Hypertens 15 (1997) 1001-1009
25. Schunkert H., Hense H.W., Holmer S.R., et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330 (1994) 1634-1638
26. Lindpaintner K., Lee M., Larson M.G., et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 334 (1996) 1023-1028
27. Messerli F.H., Kaesser U.R., and Losem C.J. Effects of antihypertensive therapy on hypertensive heart disease. Circulation 80 Suppl. 6 (1989) 145-50
28. Sakata Y., Masuyama T., Yamamoto K., et al. Renin-angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy. J Am Coll Cardiol 37 (2001) 293-299
29. Wu C.K., Tsai C.T., Hwang J.J., et al. Renin-angiotensin system gene polymorphisms and diastolic heart failure. Eur J Clin Invest 38 (2008) 789-797
30. Danser A.H., Schalekamp M.A., Bax W.A., et al. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 92 (1995) 1387-1388